Single-dose pharmacokinetics of quetiapine in subjects with renal or hepatic impairment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 4, 2000, Pages 521-533

  Thyrum, Per T ^a   Wong, Yw James ^b   Chiao, Yeh ^b  

^a ASTRAZENECA   (United Kingdom)

^b AstraZeneca ^*

Author keywords

Hepatic impairment; Pharmacokinetics; Quetiapine; Renal impairment

Indexed keywords

CREATININE; QUETIAPINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MALE; PATIENT COMPLIANCE; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; KIDNEY DISEASES; LIVER DISEASES; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 0034190597     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00090-7     Document Type: Article

References (10)

1. Arvanitis LA and Miller BG, Seroquel Trial 13 Study Group (1997) Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 42: 233-246.
2. AstraZeneca (1997) Professional Information Brochure: Seroquel (quetiapine fumarate) tablets. Delaware, USA.
3. Grimm SW, Stams KR and Bui K (1997) In vitro prediction of potential drug interactions for Seroquel [Abstract]. Schizophr Res 24: 198.
4. Gunasekara NS and Spencer CM (1998) Quetiapine: a review of its use in schizophrenia. CNS Drugs 9: 325-340.
5. Meats P (1997) Quetiapine ('Seroquel'): an effective and well tolerated atypical antipsychotic. Int J Psychiatry Clin Prac 1: 231-239.
6. Penfold NW and Park GK (1990) Effects of organ failure and therapy on drug metabolism. Curr Opin Anaesth 3: 235-240.
7. Peuskens J and Link CGG (1997) A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 96: 265-273.
8. Rowland M and Tozer TN (1989) In: Clinical Pharmacokinetics: Concepts and Applications (2nd ed). Lea and Febiger: Beckenham, Kent, UK and Malvern, Pennsylvania, USA, p183.
9. St Peter JV and Awni WM (1991) Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites. Clin Pharmacokinet 20: 50-65.
10. Wong YWJ, Ewing BJ, Thyrum PT and Yeh C (1997) Multiple-dose pharmacokinetics of 'Seroquel' (quetiapine) in schizophrenic men and women [Abstract]. Schizophr Res 24: 200.